THE INDULGENCE PARADOX

By Elisabeth Liley and Kevian Liley

Synopsis:
Dr. Nathaniel "Nate" Hollis, a thirty-four-year-old research biochemist at the University of Manchester's obscure Department of Sensory Science, accidentally discovers a modified peptide Formulation 247, that inverts human sweet taste perception, transforming sugar from pleasure into revulsion. What begins as a potential breakthrough for metabolic disorder patients rapidly spirals into a global health revolution and moral catastrophe.
When Nate tests the compound on himself and volunteers, the effect proves powerful, specific, and temporary: sweet flavours become actively repulsive while other tastes remain unaffected. Recognising its potential to combat obesity, he reluctantly partners with NutriTech, a biotechnology giant led by the charismatic and ruthless Julian Blackwood. Under Blackwood's orchestration, the compound is rebranded as "Zero" and launched with unprecedented scale, NHS pilot programmes, government endorsements, and a marketing campaign that transforms Nate into the public face of a "Wellness Crusade."
But the commercial success masks sinister transformations. Blackwood secretly substitutes a cheaper peptide analogue (Peptide-247b) that crosses the blood-brain barrier, accumulating in neural tissue and progressively destroying the brain's capacity for pleasure anhedonia. Children in school programmes suffer seizures; adults develop eating disorders and obsessive behaviours; a counterfeit market flourishes among desperate users.
Escaping through a chemical diversion and a desperate flight across the English countryside, Nate transforms from corporate prophet to fugitive whistleblower. He connects with Dr. Helena Voss (former European Medicines Agency), Rebecca Shaw (investigative journalist), Dr. Samuel Okonkwo (toxicologist), and David Chen (cybersecurity expert), a network of dissidents who help him extract damning evidence from NutriTech's secure servers. After a live BBC broadcast confession and Blackwood's arrest in Geneva, Nate believes the war is won.
It is not. Blackwood's empire metastasises into NuTaste Ventures, operating beyond extradition in Brazil, India, Indonesia, and Eastern Europe, while the original compound's neurological damage persists in untold victims. Nate devotes himself to the Receptor Restoration Project in Cambridge, developing a viral vector construct capable of regenerating damaged neural receptors. This scientific redemption comes at severe personal cost: surveillance, sabotage, burnout, and a patent challenge designed to claim ownership of the cure itself.
The novel's climax arrives not with Blackwood's eventual conviction for crimes against humanity, but with Nate's hard-won understanding that victory is not an ending but a direction. The NuTaste network, though diminished, continues; new variants emerge; the philosophical debate about pleasure, control, and medical intervention persists. Yet the cure reaches patients, the scientific community mobilises, and the regulatory frameworks evolve.
By novel's end, Nate, now in his early forties, has transformed from accidental alchemist to intentional healer, from isolated genius to collaborative leader, from corporate puppet to autonomous moral agent. THE INDULGENCE PARADOX ultimately explores the central tension of its title: that humanity's pursuit of health through the elimination of indulgence becomes its own form of tyranny, and that the restoration of pleasure, modest, balanced, freely chosen, may be the most radical resistance against systems that would control what we are permitted to feel

• Format: Paperback
• Language: English
• ISBN: B0H2KTGR9S
• ISBN13: 9798198004948
• Release Date: May 2026
• Publisher: Independently published
• Length: 230 Pages
• Weight: 0.70 lbs.
• Dimensions: 9.0" x 0.5" x 6.0"